Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Net Margin (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Net Margin for 16 consecutive years, with 3.93% as the latest value for Q3 2025.

  • Quarterly Net Margin rose 2192.0% to 3.93% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 1.32% through Sep 2025, up 1843.0% year-over-year, with the annual reading at 14.03% for FY2024, 1267.0% down from the prior year.
  • Net Margin for Q3 2025 was 3.93% at Xtant Medical Holdings, down from 10.03% in the prior quarter.
  • The five-year high for Net Margin was 36.9% in Q3 2023, with the low at 22.07% in Q4 2023.
  • Average Net Margin over 5 years is 7.6%, with a median of 11.58% recorded in 2023.
  • The sharpest move saw Net Margin skyrocketed 5317bps in 2023, then plummeted -5488bps in 2024.
  • Over 5 years, Net Margin stood at 17.04% in 2021, then rose by 15bps to 14.47% in 2022, then plummeted by -53bps to 22.07% in 2023, then soared by 54bps to 10.04% in 2024, then skyrocketed by 139bps to 3.93% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 3.93%, 10.03%, and 0.18% for Q3 2025, Q2 2025, and Q1 2025 respectively.